Active management of the third stage of labor: A brief overview of key issues
Yıl: 2018 Cilt: 15 Sayı: 3 Sayfa Aralığı: 188 - 192 Metin Dili: İngilizce DOI: 10.4274/tjod.39049 İndeks Tarihi: 19-09-2019
Active management of the third stage of labor: A brief overview of key issues
Öz: Postpartum hemorrhage is a potentially life-threatening, albeit preventable, condition that persists as a leading cause of maternal death. It occurs mostlyduring the third stage of labor, and active management of the third stage of labor (AMTSL) can prevent its occurrence. AMTSL is a recommended series ofsteps, including the provision of uterotonic drugs immediately upon fetal delivery, controlled cord traction, and massage of the uterine fundus, as developedby the World Health Organization. Here, we present current opinion and protocols for AMTSL
Anahtar Kelime: Konular:
Doğumun üçüncü evresinin aktif yönetimi: Kilit konulara kısa bir bakış
Öz: Postpartum kanama, hayatı tehdit eden, önlenebilir bir durumdur, anne ölümünün önde gelen nedenini oluşturan bir durumdur. Çoğunlukla doğumun üçüncü evresi sırasında ortaya çıkar ve doğumun üçüncü evresinin aktif yönetimi (AMTSL) ortaya çıkmasını engelleyebilir. AMTSL, uterotonik ilaçların hemen fetal doğum üzerine uygulanması, kontrollü kordon traksiyonu ve Dünya Sağlık Örgütü tarafından geliştirilen rahim fundus masajı dahil olmak üzere önerilen bir dizi adımdır. Burada AMTSL için güncel görüş ve protokolleri sunuyoruz.
Anahtar Kelime: Konular:
Belge Türü: Makale Makale Türü: Derleme Erişim Türü: Erişime Açık
- American College of Obstetricians and Gynecologists. ACOG Practice Bulletin: Clinical Management Guidelines for ObstetricianGynecologists Number 76, October 2006: postpartum hemorrhage. Obstet Gynecol 2006;108:1039-47.
- Rath WH. Postpartum hemorrhage- update on problems of definitions and diagnosis. Acta Obstet Gynecol Scand 2011:90:421- 28.
- World Health Organization WHO guidelines for the management of postpartum haemorrhage and retained placenta. Geneva: World Health Organization; 2009.
- Royal College of Obstetrician and Gynaecologists. Postpartum Hemorrhage: Prevention and Management; 2011.
- Zhu C, Estrada M, White J, Lal M. Heat-stable sublingual oxytocin tablets as a potential needle-free approach for preventing postpartum hemorrhage in low-resource settings. Drug Deliv Transl Res 2018;8:853-6.
- Oguz Orhan E, Dilbaz B, Aksakal SE, Altınbas S, Erkaya S. Prospective randomized trial of oxytocin administration for active management of the third stage of labor. Int J Gynecol Obstet 2014;127:175-9.
- Güngördük K, Asicioglu O, Besimoglu B, Güngördük OC, Yildirm G, Ark C, et al. Using intraumbilical vein injection of oxytocin in routine practice with active management of the third stage of labor: a randomized controlled trial. Obstet Gynecol 2010;116:619-24.
- Gohil JT, Tripathi B. A Study to Compare the Efficacy of Misoprostol, Oxytocin, Methyl-ergometrine and Ergometrine-Oxytocin in Reducing Blood Loss in Active Management of 3rd Stage of Labor. J Obstet Gynaecol India 2011;61:408-12.
- McDonald SJ, Abbott JM, Higgins SP. Prophylactic ergometrineoxytocin versus oxytocin for the third stage of labour. Cochrane Database Syst Rev 2004:CD000201.
- Mobeen N, Durocher J, Zuberi N, Jahan N, Blum J, Wasim S, et al. Administration of misoprostol by trained traditional birth attendants to prevent postpartum haemorrhage in homebirths in Pakistan: a randomised placebo-controlled trial. BJOG 2011;118:353-61.
- Gulmezoglu AM, Villar J, Ngoc NT, Piaggio G, Carroli G, Adetoro L, et al. WHO multicentre randomised trial of misoprostol in the management of the third stage of labour. Lancet 2001;358:689-95.
- Tuncalp Ö, Hofmeyr GJ, Gülmezoglu AM. Prostaglandins for preventing postpartum haemorrhage. Cochrane Database Syst Rev 2012:CD000494.
- WHO Recommendations for the Prevention and Treatment of Postpartum Haemorrhage. Geneva: World Health Organization; 2012.
- Tan J, Cao Q, He GL, Cai YH, Yu JJ, Sun X, et al. Misoprostol versus ergometrine-oxytocin for preventing postpartum haemorrhage: a systematic review and meta-analysis of randomized controlled trials. J Evid Based Med 2016;9:194-204.
- Hernández-Castro F, López-Serna N, Treviño-Salinas EM, SoriaLópez JA, Sordia-Hernández LH, Cárdenas-Estrada E. Randomized double-blind placebo-controlled trial of buccal misoprostol to reduce the need for additional uterotonic drugs during cesarean delivery. Int J Gynaecol Obstet 2016;132:184-7.
- Sentilhes L, Lasocki S, Ducloy-Bouthors AS, Deruelle P, Dreyfus M, Perrotin F, et al. Tranexamic acid for the prevention and treatment of postpartum haemorrhage. Br J Anaesth 2015;114:576-87.
- Draxler DF, Medcalf RL. The Fibrinolytic System-More Than Fibrinolysis? Transfus Med Rev 2015;29:102-9.
- Tengborn L, Blombäck M, Berntorp E. Tranexamic acid--an old drug still going strong and making a revival. Thromb Res 2015;135:231- 42.
- Hinshaw K. Tranexamic acid for post-partum haemorrhage in the WOMAN trial. Lancet 2017;390:1582-3.
- Li B, Miners A, Shakur H, Roberts I; WOMAN Trial Collaborators. Tranexamic acid for treatment of women with post-partum haemorrhage in Nigeria and Pakistan: a cost-effectiveness analysis of data from the WOMAN trial. Lancet Glob Health 2018;6:222-8.
- Gai M, Wu L, Su Q, Tatsumoto K. Clinical observation of blood loss reduced by tranexamic acid during and after caesarean section: a multi-center, randomized trial. Eur J Obstet Gynecol Reprod Biol 2004;112:154-7.
- Mayur G, Purvi P, Ashoo G, Pankaj D. Efficacy of tranexamic acid in decreasing blood loss during and after caesarean section: a randomized case controlled prospective study. J Obstet Gynecol India 2007;57:227-30.
- Sekhavat L, Tabatabaii A, Dalili M, Farajkhoda T, Tafti AD. Efficacy of tranexamic acid in reducing blood loss after caesarean section. J Matern Fetal Neonatal Med 2009;22:72-5.
- Gungorduk K, Yıldırım G, Asıcıoğlu O, Gungorduk OC, Sudolmus S, Ark C. Efficacy of intravenous tranexamic acid in reducing blood loss after elective cesarean section: a prospective, randomized, doubleblind, placebo-controlled study. Am J Perinatol 2011;28:233-40.
- Movafegh A, Eslamian L, Dorabadi A. Effect of intravenous tranexamic acid administration on blood loss during and after caesarean delivery. Int J Gynecol Obstet 2011;115:224-6.
- Xu J, GaoW, Ju Y. Tranexamic acid for the prevention of postpartum haemorrhage after caesarean section: a double-blind randomization trial. Arch Gynecol Obstet 2013;287:463-8.
- Sentürk MB, Cakmak Y, Yildiz G, Yildiz P. Tranexamic acid for caesarean section: a double-blind, placebo-controlled, randomized clinical trial. Arch Gynecol Obstet 2013;287: 641-5.
- Shahid A, Khan A. Tranexamic acid in decreasing blood loss during and after caesarean section. J Coll Physicians Surg 2013;23:459-62.
- Abdel-Aleem H, Alhusaini TK, Abdel-Aleem MA, Menoufy M, Gülmezoglu AM. Effectiveness of tranexamic acid on blood loss in patients undergoing elective caesarean section: randomized clinical trial. J Matern Fetal Neonatal Med 2013;26:1705-9.
- Goswami U, Sarangi S, Gupta S, Babbar S. Comparative evaluation of two doses of tranexamic acid used prophylactically in anemic parturients for lower segment caesarean section: A doubleblind randomized case control prospective trial. Saudi J Anaesth 2013;7:427-31.
- Ahmed MR, Sayed Ahmed WA, Madny EH, Arafa AM, Said MM. Efficacy of tranexamic acid in decreasing blood loss in elective caesarean delivery. J Matern Fetal Neonatal Med 2015;28:1014-8.
- Yang H, Zheng S, Shi C. Clinical study on the efficacy of tranexamic acid in reducing postpartum blood lose: a randomized, comparative, multicenter trial. Zhonghua Fu Chan Ke Za Zhi 2001;36:590-2.
- Mirghafourvand M, Mohammad-Alizadeh S, Abbasalizadeh F, Shirdel M. The effect of prophylactic intravenous tranexamic acid on blood loss after vaginal delivery in women at low risk of postpartum haemorrhage: a double-blind randomised controlled trial. Aust N Z J Obstet Gynaecol 2015;55:53-8.
- Ducloy-Bouthors AS, Jude B, Duhamel A, Huissoud C, Keita-Meyer H, Mandelbrot L, et al. High-dose tranexamic acid reduces blood loss in postpartum haemorrhage. Crit Care 2011;15:117.
- Gungorduk K, Asıcıoglu O, Yıldırım G, Ark C, Tekirdag Aİ, Besımoglu B. Can intravenous injection of tranexamic acid be used in routine practice with active management of the third stage of labor in vaginal delivery? A randomized controlled study. Am J Perinatol 2013;230:407-13.
- Hofmeyr GJ, Mshweshwe NT, Gülmezoglu AM. Controlled cord traction for the third stage of labour. Cochrane Database Syst Rev 2015:1:CD008020.
- Güngördük K, Asicioglu O, Celikkol O, Olgac Y, Ark C. Use of additional oxytocin to reduce blood loss at elective caesarean section: A randomised control trial. Austr N Z J Obstet Gynaecol 2010;50:36- 9.
- Chen M, Chang Q, Duan T, He J, Zhang L, Liu X. Uterine massage to reduce blood loss after vaginal delivery: a randomized controlled trial. Obstet Gynecol 2013;122:290-5.
- Begley CM, Gyte GM, Devane D, McGuire W, Weeks A. Active versus expectant management for women in the third stage of labour. Cochrane Database of Syst Rev 2015:CD007412.
| APA | Gungorduk K, OLGAÇ Y, Gülseren V, kocaer m (2018). Active management of the third stage of labor: A brief overview of key issues. , 188 - 192. 10.4274/tjod.39049 |
| Chicago | Gungorduk Kemal,OLGAÇ Yusuf,Gülseren Varol,kocaer mustafa Active management of the third stage of labor: A brief overview of key issues. (2018): 188 - 192. 10.4274/tjod.39049 |
| MLA | Gungorduk Kemal,OLGAÇ Yusuf,Gülseren Varol,kocaer mustafa Active management of the third stage of labor: A brief overview of key issues. , 2018, ss.188 - 192. 10.4274/tjod.39049 |
| AMA | Gungorduk K,OLGAÇ Y,Gülseren V,kocaer m Active management of the third stage of labor: A brief overview of key issues. . 2018; 188 - 192. 10.4274/tjod.39049 |
| Vancouver | Gungorduk K,OLGAÇ Y,Gülseren V,kocaer m Active management of the third stage of labor: A brief overview of key issues. . 2018; 188 - 192. 10.4274/tjod.39049 |
| IEEE | Gungorduk K,OLGAÇ Y,Gülseren V,kocaer m "Active management of the third stage of labor: A brief overview of key issues." , ss.188 - 192, 2018. 10.4274/tjod.39049 |
| ISNAD | Gungorduk, Kemal vd. "Active management of the third stage of labor: A brief overview of key issues". (2018), 188-192. https://doi.org/10.4274/tjod.39049 |
| APA | Gungorduk K, OLGAÇ Y, Gülseren V, kocaer m (2018). Active management of the third stage of labor: A brief overview of key issues. Turkish Journal of Obstetrics and Gynecology, 15(3), 188 - 192. 10.4274/tjod.39049 |
| Chicago | Gungorduk Kemal,OLGAÇ Yusuf,Gülseren Varol,kocaer mustafa Active management of the third stage of labor: A brief overview of key issues. Turkish Journal of Obstetrics and Gynecology 15, no.3 (2018): 188 - 192. 10.4274/tjod.39049 |
| MLA | Gungorduk Kemal,OLGAÇ Yusuf,Gülseren Varol,kocaer mustafa Active management of the third stage of labor: A brief overview of key issues. Turkish Journal of Obstetrics and Gynecology, vol.15, no.3, 2018, ss.188 - 192. 10.4274/tjod.39049 |
| AMA | Gungorduk K,OLGAÇ Y,Gülseren V,kocaer m Active management of the third stage of labor: A brief overview of key issues. Turkish Journal of Obstetrics and Gynecology. 2018; 15(3): 188 - 192. 10.4274/tjod.39049 |
| Vancouver | Gungorduk K,OLGAÇ Y,Gülseren V,kocaer m Active management of the third stage of labor: A brief overview of key issues. Turkish Journal of Obstetrics and Gynecology. 2018; 15(3): 188 - 192. 10.4274/tjod.39049 |
| IEEE | Gungorduk K,OLGAÇ Y,Gülseren V,kocaer m "Active management of the third stage of labor: A brief overview of key issues." Turkish Journal of Obstetrics and Gynecology, 15, ss.188 - 192, 2018. 10.4274/tjod.39049 |
| ISNAD | Gungorduk, Kemal vd. "Active management of the third stage of labor: A brief overview of key issues". Turkish Journal of Obstetrics and Gynecology 15/3 (2018), 188-192. https://doi.org/10.4274/tjod.39049 |
